| abstract |
Provided are a novel quinoline derivative, a pharmaceutically acceptable salt, a hydrate thereof, or a metabolite formed in any metabolic form, and the use in preparing a drug for preventing and/or treating indications associated with angiogenesis. The quinoline derivative is an ideal and high-efficiency VEGFR inhibitor, able to be used to treat or prevent tumour growth, and other metastasis growth diseases associated with angiogenesis. |